Try our beta test site
37 studies found for:    Fluad
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years
Conditions: Influenza;   Streptococcus Pneumoniae
Interventions: Biological: Fluad and Prevenar13;   Biological: Fluad;   Biological: Prevenar13
2 Completed Seasonal Flu Vaccine in Adult Transplant Recipients
Conditions: Immunocompromised;   Transplanted
Intervention: Biological: Fluad 1x
3 Active, not recruiting Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses
Condition: Safety Markers of Adjuvanted Influenza Vaccine
Interventions: Biological: Fluad;   Biological: Saline
4 Completed Training Study to Characterize Biomarkers to Flu Vaccines
Condition: Healthy
Interventions: Biological: Fluad;   Biological: Agrippal;   Biological: Placebo
5 Completed Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
Condition: Influenza
Intervention: Biological: Pandemic influenza vaccine
6 Completed MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine
Conditions: Influenza, Human;   Pneumococcal Infections
Interventions: Biological: Fluad alone;   Biological: Fluad and PPV23 on the different arms;   Biological: Fluad and PPV23 on the same arm;   Biological: PPV23 alone
7 Completed Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis
Conditions: Influenza;   End Stage Renal Failure;   Chronic Kidney Disease
Interventions: Biological: Fluad;   Biological: Agrippal
8 Active, not recruiting Adjuvanted Influenza Vaccination in U.S. Nursing Homes
Conditions: Influenza;   Influenza-like Illness
Interventions: Biological: adjuvanted trivalent influenza vaccine;   Biological: trivalent influenza vaccine
9 Completed
Has Results
Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects
Condition: Human Influenza
Intervention: Biological: Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)
10 Unknown  Influenza Vaccination Among the Elderly Individuals
Condition: Influenza
Intervention: Biological: FLUAD 2014/2015
11 Completed
Has Results
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age
Condition: Influenza Disease
Interventions: Biological: Trivalent split influenza vaccine (TIV);   Biological: MF59-adjuvanted trivalent influenza vaccine (aTIV);   Biological: Licensed comparator trivalent split influenza vaccine (comparator TIV)
12 Completed
Has Results
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Condition: Influenza
Intervention: Biological: MF59-adjuvanted trivalent influenza subunit vaccine
13 Completed ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses
Condition: Influenza
Interventions: Biological: TIV (Aggripal);   Biological: ATIV (Fluad)
14 Completed
Has Results
Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010
Condition: Seasonal Influenza
Intervention: Biological: Seasonal Influenza Vaccine (MF59C.1)
15 Completed
Has Results
Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009
Condition: Interpandemic Influenza
Intervention: Biological: Seasonal Influenza Vaccine
16 Recruiting Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children
Condition: Influenza
Interventions: Biological: Fluad;   Biological: Fluzone
17 Not yet recruiting Adjuvanted Influenza Vaccine in Stem Cell Transplant
Conditions: Transplantation;   Influenza Vaccines
Interventions: Biological: FLUAD® influenza vaccine;   Biological: FLUVIRAL®
18 Completed Gene Expression Profiles in Muscle After Immunisation
Condition: Healthy
Interventions: Biological: Fluad;   Biological: Fendrix;   Biological: Placebo
19 Active, not recruiting ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults
Condition: Influenza
Intervention: Biological: MF59 - ATIV
20 Completed Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
Condition: Prophylaxis of Avian Influenza Vaccine
Intervention: Biological: Fluad H5N1 Pandemic Influenza Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.